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Abstract 
Objective 
To devise a feasible composite radiographic score for use in observational studies of 
Psoriatic Arthritis (PsA).  
Methods 
Radiographs from 50 patients with PsA were scored with the PsA-modified Sharp, 
Sharp-van der Heijde and Ratingen scores.  Data reductions were made to devise a 
concise score.  
Results 
The Reductive X-ray Score for Psoriatic Arthritis (ReXSPA) requires the assessment 
of only 22 joints (117 points) including erosion, joint space narrowing and 
osteoproliferation in the hands and feet.  The ReXSPA accounts for 80% of change 
detected with the Sharp-van der Heijde score. 
Conclusion  
We report a proof of concept radiographic score for observational studies derived 
though data reduction.   
Introduction 
The measurement of radiographic joint damage is highly valuable in characterising 
disease severity, progression and prognosis in longitudinal observational studies of 
psoriatic arthritis (PsA).  An essential attribute of a scoring method for use in large 
longitudinal observational studies is that it can be applied feasibly, within the 
constraints of cost and time.  Existing radiographic measures are time consuming to 
perform leading to limited data collection from existing longitudinal observational 
studies.  Radiographic damage is frequently reported as the presence or absence of 
damage.  The only radiographic measure currently used on a routine basis is the 
modified Steinbrocker global score.1  In the modified Steinbrocker score the 
radiographic features of soft tissue swelling, osteopenia, erosion, joint space 
narrowing, lysis and ankylosis are combined in to a single numeric value for each 
joint.  Combining the radiographic features reduces the time taken to perform the 
score and has the added advantage of following the presumed, but unproven, order of 
radiographic progression.  Composite scores have been developed for use in PsA 
which require radiographic features to be assessed and scored separately for erosion 
and joint space narrowing (PsA-modified Sharp Score2 and the Sharp-van der Heijde 
score3) or erosion and osteoproliferation (PsA Ratingen score4).  We have previously 
reported a comparison of the feasibility, reliability and sensitivity to change of these 
existing radiographic scores used in PsA.5  The modified Sharp and Sharp-van der 
Heijde methods were found to be the most reliable and sensitive to change, but took 
longer to perform.  The modified Steinbrocker was the most feasible, taking 
approximately half the time to score, but lacks the sensitivity of the composite 
methods.   
 
 Our objective was to devise a more feasible composite radiographic score, through a 
reductive analysis of existing composite scores, for use in large longitudinal 
observational studies.  
 
Materials and Methods: 
We have previously reported the details of the patient selection, radiographic 
techniques and scoring methods used in this study.5  In brief, standard antero-posterior 
radiographs of the hands and forefeet from 50 patients with PsA were scored at two 
time points with each of the PsA-modified Sharp, Sharp-van der Heijde and Ratingen 
scores.1 All selected patient’s fulfilled the Classification Criteria for Psoriatic Arthritis 
(CASPAR) criteria.6, 7  Radiographs were scored by the authors WT and DJ in known 
chronological order to optimise sensitivity to change and since observational studies 
usually score radiographs in known order.  
 
Statistical analysis was undertaken in the statistical package R (2014) [http://www.R-
project.org/.]. Analysis was performed on cases who demonstrated progressive 
disease of any radiographic feature during the follow up period. The aim was to apply 
data reduction techniques to a dataset consisting of changes (progression) in each of 
the components of the radiographic scores. Subsets selection using simulated 
annealing based on principle components analysis8 was used to find optimal subsets 
based on the RM coefficient, a measure of the similarity between a reduced dataset 
and the original. The coefficient ranges from 0 to 1, with larger values indicating 
strong similarity and higher proportions of explained variation. The fewest number of 
variables that would give RM >0.9 was found. Initially, this was performed on the full 
dataset using all variables, from all scores, constrained only to make a symmetrical 
score.  A second analysis had the additional constraint that scoring of erosion or joint 
narrowing had to be consistent within each of the scoring methods. Finally, the 
analysis was restricted to exclude small wrist joints as these were felt to be time 
consuming to score and, debatably, less clinically relevant. A number of candidate 
scoring systems fulfilling the specified criteria performed very similarly (RM 
coefficients within 0.001). Choosing the final scoring system based on the best 
performing would have been arbitrary and instead we selected the most ‘clinically 
reasonable’ scoring system. The performance of the finally derived novel score was 
assessed according to its ability to predict progression as measured by the PsA-
modified Sharp, Sharp-van der Heijde, Ratingen scores. 
 
Results: 
The patients’ mean age was 54.6 years, mean disease duration 17.6 years and mean 
follow up 2.1 years. Inter/intra-rater reliability were excellent for all methods (ICC 
>0.89).5  Details on the radiographic damage of the cohort are included in a 
supplementary file (Supp Table 1). The first reduction (the full dataset, restricted only 
to be symmetrical) identified a score comprising 24 variables.  The second analysis 
(further restricted to only one method of joint space narrowing and erosion, excluding 
small wrist joints) as detailed in the methods section identified six possible scores of 
which is reported here (Table 1).  The resulting Reductive X-ray Score for Psoriatic 
Arthritis (ReXSPA) score requires the assessment of only 22 joints and a score out of 
117 points.  This is compared to 42 variables (168 points) for the modified 
Steinbrocker or 104 (528 points) for Sharp-van der Heijde score.  Within this dataset 
the ReXSPA score accounts for over 90% of the variance of the full dataset and has a 
sensitivity to change of 80% when detecting progression as defined by the most 
sensitive score, the Sharp-van der Heijde (Table 1).  
 
The joints included in the finally selected model are illustrated in Figure 1 and scales 
for the measurements in Table 2.  Assessment of joint space narrowing and erosion is 
made using the scale from the Sharp-van der Heijde score and osteoproliferation using 
the PsA Ratingen scale at the hands, wrist and feet.  Ankylosis was only scored in the 
Sharp-van der Heijde joint space narrowing score.  
 
Discussion 
We propose a novel composite radiographic score for longitudinal observational 
studies that is sensitive to change and includes three hallmark features of PsA, 
erosion, joint space narrowing and osteoproliferation.  This novel score requires fewer 
joints to be assessed than the other most commonly used score in observational 
studies, the PsA-modified Steinbrocker, whilst maintaining a similar sensitivity to 
change as the Sharp-van der Heijde score.  
 
Global scores are briefer and quicker to perform but have the significant disadvantage 
of combining data into a single numeric value.  Raw data on individual radiographic 
features (domains) is therefore not available for future sub-analysis.  In comparison 
composite scores have the advantage of being more sensitive to change and able to 
preserve the data relating to specific radiographic features. For example, data may be 
required from existing cohorts for a genetic association study where specificity of 
joint damage is the most important attribute. A composite score allows for separate 
analysis of erosion or, in the case of the Ratingen score, osteoproliferation, the only 
radiographic feature sufficiently specific to PsA to be included in the classification 
criteria for psoriatic arthritis (CASPAR) criteria.6  
 
The ReXSPA is a tool proposed for observational cohorts to allow large scale data 
collection.  We believe that none of the existing scores are optimal for use in the 
observational setting.  The modified Steinbrocker may be considered feasible (readily 
learned and applied in our dataset in a mean of 6.2 minutes) but it is not sufficiently 
sensitive to change, does not allow sub-analysis of individual radiographic features, 
does not include osteoproliferation, and scores for osteopenia, which is both rare in 
PsA and prone to inter-rater variability.5  The Sharp-van der Heijde score is sensitive 
to change and readily learned, but takes more than twice as long to perform (mean of 
14.4 minutes in our dataset), the difference between scoring nearly ten films in an 
hour versus four.5  
 
A strength of the approach we have taken in this present study is to allow the data 
(sensitivity to change) to determine the final score, however we recognise other 
approaches could have been taken.  It would be possible to reduce an existing score, 
such an approach has been adopted with the Psoriatic Arthritis Impact of Disease 
score with two versions available, 9 and 12 domains.9  The Sharp-van der Heijde 
score may seem the most suitable method for this approach but would not include 
osteoproliferation which is specific to PsA and has been shown to be sensitive to 
change.5  Alternatively the Ratingen score does not include joint space narrowing, 
which is clinically relevant and sensitive to change.  On this basis, we believe that 
using the full dataset of all variables (joint space narrowing, erosion and 
osteoproliferation from all joints) with data driven selection has justified our 
approach. Though this present study is large for a comparison of radiographic 
measures, the score has been derived from a small group of patients and needs to be 
applied in the clinical setting in a larger dataset.  Furthermore, the ReXSPA score 
remains a proposal derived from the existing dataset and feasibility and reliability are 
yet to be formally determined. Finally the radiographs were scored in known 
chronological order. Whilst this is consistent with the intended clinical use in the 
observational setting (and optimizes sensitivity to change) the approach has the 
potential to introduce expectation bias.   
 
In conclusion, we report a proof of concept radiographic score for observational 
studies in PsA derived though data reduction. The composite ReXSPA score has a 
similar sensitivity as the Sharp-Van der Heijde, the most sensitive method developed, 
but is briefer than the modified Steinbrocker, the most feasible method.  This 
ReXSPA score can now be further assessed in larger studies. 
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Table 1- Correlation, sensitivity and area under curve analyses of the novel ReXSPA 
score compared with existing methods. 
Score Spearman 
Correlation 
coefficient 
Sensitivity 
Any change (full dataset)  0.77 
VDH 0.88 0.80 
MSS 0.84 0.82 
Ratingen 0.67 0.86 
VDH Erosion 0.75 0.96  
MSS Erosion 0.73 0.96 
Ratingen destruction 0.62 0.95 
VDH joint space narrowing 0.69 0.79 
MSS joint space narrowing 0.69 0.84 
Ratingen proliferation 0.54 0.86 
VDH: Sharp-Van der Heijde 
MSS: Modified Sharp score 
ReXSPA: Reductive X-ray Score for Psoriatic Arthritis 
Sensitivity is defined as the ability to predict progression in a patient defined as any 
recorded change in the given scoring system.    
 
  
Table 2 – ReXPSA score scales 
 
P=proliferation 
From PsA Ratingen score 
E=erosion 
From Sharp-van der Heijde 
N=joint space narrowing 
From Sharp-van der 
Heijde 
0 = normal. 0 = no erosions. 0 = normal 
1 = bony proliferation measured from 
the original bone surface of 1-2mm, 
or clearly identifiable bone growth 
not exceeding 25% of the original 
diameter of the bone.  
1= discrete erosion. 1 = asymmetrical minimal 
narrowing with loss of up 
to a maximum of 25% 
2 = bony proliferation of 2-3mm or 
bone growth between 25 to 50%  
2 = large erosion not passing 
the midline. 
2 = definite narrowing 
with loss of up to 50% of 
the normal space 
3 = bony proliferation >3mm or bone 
growth >50% 
3 = large erosion passing the 
mid-line. 
3 = definite narrowing 
with loss of 50 – 99% of 
the normal space or 
subluxation 
 4 = combination of above 4 = absence of a joint 
space, presumptive 
evidence of ankylosis, or 
complete subluxation. 
 5 = combination of above  
Proliferation score /18 points Erosion score /55 points Joint space narrowing 
score /44 points 
Total score /117 
 
 
  
Figure  1 Joints assessed in the ReXPSA score 
 
 
 
E: Erosion 
P: Osteoproliferation 
N: Joint Space Narrowing 
 
